Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
Animal Pharm
Email ID
Password
Forgotten password?
Sign me in automatically next time
Advanced Search
Home
Product Sector
Regulatory Region
Pre-marketing Regulation
Post-marketing Regulation
Healthcare Systems
Legal
Africa
|
Asia
|
Australasia
|
Europe
|
International
|
Latin America
|
North America
|
Scrip Regulatory Affairs
Trademarks Briefing (Pharma) - China
24 September 2009
Please give details of the major acts and directives governing trademarks.
The main legislation governing trademarks in China include:
Laws:
Trademark Law of The People’s Republic of China, 23 August 1982, as amended.
Please login to read the full article.
Not a subscriber ?
Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
US biotech industry welcomes Supreme Court ruling against Microsoft
US Supreme Court upholds "clear and convincing" patent standard, rules against Microsoft
EU court offers guidance on pharma's role in providing info to patients
Supreme Court takes another stab at refining US patent law
Other Informa News
Potential lack of standing could end Myriad case with no DNA patent resolution
Potential lack of standing could end Myriad case with no DNA patent resolution
ANALYSIS
Regulatory Affairs Pharma Analysis
The new EU legislation on falsified medicines: is it a step in the wrong direction?
Reckitt Benckiser: the sour aftertaste of a settlement with the OFT in the UK
Other Informa Analysis
How to Leverage India: Visions of 2020
Global pharma boosts business in Russia - Why Russia (introduction)
EDITORIALS
Regulatory Affairs Pharma Editorials
Legislation on information to patients in the EU - will it be worth the effort?
New faces at the EMA
Other Informa Editorials
Information and control
Comfort from a poke in the eye
FEATURES
Regulatory Affairs Pharma Features
Registering and marketing medicines in Brazil
Synthon and Generics rulings and the scope of the SPC Regulation in the EU: a creative approach or a step too far?
Other Informa Features
Refurbishment and reprocessing - threat or opportunity for medical device manufacturers?
The European clinical diagnostics market ? Italy and the UK
COMMENT
Regulatory Affairs Pharma Comment
Danes urge austerity as EU health issues loom large
Other Informa Comments
Information and control
About Us
Getting Started
Free Trial
Subscribe
Advertise
Guidelines for Authors
Blog